Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Publisher
BioPharm International(1)
Clinical Cancer Research(1)
Expert Review of Respiratory Medicine(1)
Origen
scopus(3)
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
ArticleAbstract: Purpose: EGFR is a well-validated target for patients with non-small cell lung cancer (NSCLC). CIMAvPalabras claves:Autores:Acosta S.C., Aguilera N., Alonso L., Amador R.M., Arzuaga L., Cala M., Carmen Elena Viada, Catala M., Crespo T., De La Torre A.V., Fleytas R., Flores Y.I., Futiel N., García Verdecia B., Lage Davila A., Luaces P.L.o., Marrero Miragaya M.A., Martínez O., Mazorra Z., Mendoza S., Neninger Vinageras E., Otero Y., Parra J., Pomares Y., Popa X., Reyes D., Rodríguez G., Rodríguez P.C., Romero G.N., Sabates T., Santiesteban E.R., Sierra P., Tania Crombet, Vello L.Fuentes:scopusManufacturing process development for an epidermal growth factor-based cancer vaccine
ArticleAbstract: The Center for Molecular Immunology (Havana, Cuba) has been working on a novel cancer immunotherapyPalabras claves:Autores:Albisa A., Calvo L., Chico E., Cuevas A., Garcia A.T., García Verdecia B., González G., Portillo A., Rodríguez G., Tania Crombet, Viña L.Fuentes:scopusTherapeutic vaccination with an EGF-based vaccine in lung cancer: A step in the transition to a chronic disease
ArticleAbstract: The trend of increased survival in advanced tumors suggests the possibility of the transformation ofPalabras claves:cancer vaccine, EGF/EGFR binding inhibition, Epidermal growth factor, immunotherapy, lung cancerAutores:González G., Lage Davila A., Rodríguez G., Tania CrombetFuentes:scopus